728
Participants
Start Date
October 26, 2020
Primary Completion Date
October 28, 2023
Study Completion Date
October 28, 2023
Other: Non intervention
Non intervention
Pyeongchon Maria, 8/9F, Olympic Sports Center120, Dongan-ro, Dongan-gu, Anyang
Dream-I clinic, 45-17, Huimang-ro 46beon-gil, Baebang-eup, Asan
Centum Eroom Woman Clinic, 10F, Centum Tower Medical, 20, Centum-2-ro, Haeundae-gu, Busan
Eroom women's clinic, 25, Seomyeon-ro, Busanjin-gu, Busan
Seoul Women's Hospital, 7, Munjeong-ro, Seo-gu, Daejeon
Creation And Love Women's Hospital, 957, Mujin-daero, Seo-gu, Gwangju
Mirae and Heemang Women's Hospital, 7F, Dana Medical Center, 68, Jukbong-daero, Seo-gu, Gwangju
Design Hospital, Jeonju
Trinium Woman's Hospital, 1834, MainTower, Hannuridae-ro, Sejong
CHA university Bundang medical center, 59, Yatap-ro, Bundang-gu, Seongnam
Seoul Nation University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam
M Fertility Center, 12F, 407, Teheran-ro, Gangnam-gu, Seoul
MariaS (Sangbong), 267, Mangu-ro, Jungnang-gu, Seoul
Mizmedi Hospital, 295, Gangseo-ro, Gangseo-gu, Seoul
Seoul Maria Fertility Hospital, 20, Cheonho-daero, Dongdaemun-gu, Seoul
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY